PRHSX vs. FBTAX
Compare and contrast key facts about T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Advisor Biotechnology Fund Class A (FBTAX).
PRHSX is managed by T. Rowe Price. It was launched on Dec 29, 1995. FBTAX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
PRHSX vs. FBTAX - Performance Comparison
Loading graphics...
PRHSX vs. FBTAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | -9.65% | 33.71% | 1.82% | 3.03% | -12.22% | 13.50% | 30.19% | 37.88% | 1.08% | 28.04% |
FBTAX Fidelity Advisor Biotechnology Fund Class A | -2.70% | 39.54% | 5.37% | 10.70% | -7.95% | -3.10% | 32.17% | 25.74% | -3.86% | 25.80% |
Returns By Period
In the year-to-date period, PRHSX achieves a -9.65% return, which is significantly lower than FBTAX's -2.70% return. Both investments have delivered pretty close results over the past 10 years, with PRHSX having a 11.42% annualized return and FBTAX not far behind at 11.31%.
PRHSX
- 1D
- 0.37%
- 1M
- -9.33%
- YTD
- -9.65%
- 6M
- 18.49%
- 1Y
- 20.86%
- 3Y*
- 9.06%
- 5Y*
- 4.83%
- 10Y*
- 11.42%
FBTAX
- 1D
- -0.76%
- 1M
- -6.06%
- YTD
- -2.70%
- 6M
- 11.41%
- 1Y
- 42.70%
- 3Y*
- 18.47%
- 5Y*
- 7.93%
- 10Y*
- 11.31%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PRHSX vs. FBTAX - Expense Ratio Comparison
PRHSX has a 0.80% expense ratio, which is lower than FBTAX's 1.00% expense ratio.
Return for Risk
PRHSX vs. FBTAX — Risk / Return Rank
PRHSX
FBTAX
PRHSX vs. FBTAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Sciences Fund (PRHSX) and Fidelity Advisor Biotechnology Fund Class A (FBTAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PRHSX | FBTAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.92 | 1.56 | -0.65 |
Sortino ratioReturn per unit of downside risk | 1.60 | 2.10 | -0.50 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.27 | -0.06 |
Calmar ratioReturn relative to maximum drawdown | 1.52 | 2.38 | -0.86 |
Martin ratioReturn relative to average drawdown | 4.47 | 9.61 | -5.14 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| PRHSX | FBTAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.92 | 1.56 | -0.65 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.27 | 0.34 | -0.07 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.58 | 0.46 | +0.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.63 | 0.30 | +0.32 |
Correlation
The correlation between PRHSX and FBTAX is 0.89, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
PRHSX vs. FBTAX - Dividend Comparison
PRHSX's dividend yield for the trailing twelve months is around 26.63%, more than FBTAX's 1.49% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRHSX T. Rowe Price Health Sciences Fund | 26.63% | 24.06% | 12.89% | 5.21% | 1.77% | 7.46% | 7.16% | 12.29% | 6.57% | 7.43% | 4.55% | 11.34% |
FBTAX Fidelity Advisor Biotechnology Fund Class A | 1.49% | 1.45% | 6.00% | 1.15% | 0.00% | 20.12% | 8.37% | 6.77% | 2.50% | 0.00% | 0.00% | 5.36% |
Drawdowns
PRHSX vs. FBTAX - Drawdown Comparison
The maximum PRHSX drawdown since its inception was -42.96%, smaller than the maximum FBTAX drawdown of -63.55%. Use the drawdown chart below to compare losses from any high point for PRHSX and FBTAX.
Loading graphics...
Drawdown Indicators
| PRHSX | FBTAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.96% | -63.55% | +20.59% |
Max Drawdown (1Y)Largest decline over 1 year | -12.81% | -13.60% | +0.79% |
Max Drawdown (5Y)Largest decline over 5 years | -27.61% | -36.51% | +8.90% |
Max Drawdown (10Y)Largest decline over 10 years | -28.97% | -38.82% | +9.85% |
Current DrawdownCurrent decline from peak | -12.49% | -7.25% | -5.24% |
Average DrawdownAverage peak-to-trough decline | -8.75% | -21.34% | +12.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.36% | 4.11% | +0.25% |
Volatility
PRHSX vs. FBTAX - Volatility Comparison
The current volatility for T. Rowe Price Health Sciences Fund (PRHSX) is 5.30%, while Fidelity Advisor Biotechnology Fund Class A (FBTAX) has a volatility of 7.76%. This indicates that PRHSX experiences smaller price fluctuations and is considered to be less risky than FBTAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| PRHSX | FBTAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.30% | 7.76% | -2.46% |
Volatility (6M)Calculated over the trailing 6-month period | 15.97% | 16.36% | -0.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.33% | 25.58% | -3.25% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.01% | 23.24% | -5.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.65% | 24.55% | -4.90% |